Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott T Tagawa

Showing results (21-30 of 208) with videos related to

Pageof 21
Sort By:
Investigational New Drugs|May 4, 2004
Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC)Valerie Israel, Scott T Tagawa, Terry Snyder, et al.
Asian Journal of Andrology|May 31, 2014
Exploring the role of anti-angiogenic therapies in prostate cancer: results from the phase 3 trial of sunitinibHimisha Beltran, Gurveen Kaur, Carmen Garcías de España, et al.
Current Oncology Reports|March 29, 2021
Prostate-Specific Membrane Antigen (PSMA)-Targeted Radionuclide Therapies for Prostate CancerMichael Sun, Muhammad Junaid Niaz, Muhammad Obaid Niaz, et al.
Cancer|February 14, 2006
Survival analysis after resection of metastatic disease followed by peptide vaccines in patients with Stage IV melanomaScott T Tagawa, Eric Cheung, Warren Banta, et al.
Advances in Urology|August 4, 2011
Prostate-specific membrane antigen-based therapeuticsNaveed H Akhtar, Orrin Pail, Ankeeta Saran, et al.
Seminars in Interventional Radiology|March 6, 2014
Immunologics and chemotherapeutics for renal cell carcinomaElan Diamond, Jamie Riches, Bishoy Faltas, et al.
Current Opinion in Urology|January 23, 2025
Antibody-drug conjugates in urothelial carcinoma: current status and futureSamuel Ruder, Juana Martinez, Jessica Palmer, et al.
Expert Opinion on Therapeutic Patents|April 16, 2013
PSMA-targeted dendrimers: a patent evaluation (WO2012078534)Naveed H Akhtar, Joseph R Osborne, Shoaib B Fareedy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2019
Clinical Significance of AR-V567es in Prostate Cancer-ResponseScott T Tagawa, Emmanuel S Antonarakis, Ada Gjyrezi, et al.
Future Oncology (London, England)|December 13, 2017
A critical review on ramucirumab in the treatment of advanced urothelial cancerPanagiotis J Vlachostergios, Aileen Lee, Charlene Thomas, et al.
Pageof 21

Showing results (21-30 of 208) with videos related to

Sort By:
Pageof 21
Investigational New Drugs|May 4, 2004
Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC)Valerie Israel, Scott T Tagawa, Terry Snyder, et al.
Asian Journal of Andrology|May 31, 2014
Exploring the role of anti-angiogenic therapies in prostate cancer: results from the phase 3 trial of sunitinibHimisha Beltran, Gurveen Kaur, Carmen Garcías de España, et al.
Current Oncology Reports|March 29, 2021
Prostate-Specific Membrane Antigen (PSMA)-Targeted Radionuclide Therapies for Prostate CancerMichael Sun, Muhammad Junaid Niaz, Muhammad Obaid Niaz, et al.
Cancer|February 14, 2006
Survival analysis after resection of metastatic disease followed by peptide vaccines in patients with Stage IV melanomaScott T Tagawa, Eric Cheung, Warren Banta, et al.
Advances in Urology|August 4, 2011
Prostate-specific membrane antigen-based therapeuticsNaveed H Akhtar, Orrin Pail, Ankeeta Saran, et al.
Seminars in Interventional Radiology|March 6, 2014
Immunologics and chemotherapeutics for renal cell carcinomaElan Diamond, Jamie Riches, Bishoy Faltas, et al.
Current Opinion in Urology|January 23, 2025
Antibody-drug conjugates in urothelial carcinoma: current status and futureSamuel Ruder, Juana Martinez, Jessica Palmer, et al.
Expert Opinion on Therapeutic Patents|April 16, 2013
PSMA-targeted dendrimers: a patent evaluation (WO2012078534)Naveed H Akhtar, Joseph R Osborne, Shoaib B Fareedy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2019
Clinical Significance of AR-V567es in Prostate Cancer-ResponseScott T Tagawa, Emmanuel S Antonarakis, Ada Gjyrezi, et al.
Future Oncology (London, England)|December 13, 2017
A critical review on ramucirumab in the treatment of advanced urothelial cancerPanagiotis J Vlachostergios, Aileen Lee, Charlene Thomas, et al.
Pageof 21